Spots Global Cancer Trial Database for Assessing Quality of Life of Patients With Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessing Quality of Life of Patients With Prostate Cancer
Official Title: An International Field Study Of The Reliability And Validity Of The EORTC QLQ-C30 And A Disease-Specific Questionnaire Module (QLQ-PR25) For Assessing Quality Of Life Of Patients With Prostate Cancer
Study ID: NCT00041301
Conditions
Interventions
Study Description
Brief Summary: RATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate and long-term effects of the treatment on these patients. PURPOSE: Clinical trial to study the effectiveness of two questionnaires in assessing quality of life of patients who have prostate cancer.
Detailed Description: OBJECTIVES: * Assess the scale structure, psychometric validity, and reliability of quality of life measurements using the EORTC QLQ-C30 and the prostate cancer-specific QLQ-PR25 questionnaires in patients with stage I-IV prostate cancer. OUTLINE: This is a multicenter study. Patients are stratified according to stage of disease (local or locally advanced disease vs metastatic disease). Patients complete EORTC QLQ-C30 and prostate cancer-specific QLQ-PR25 questionnaires before therapy and at 3 months after the start of therapy. Patients in stratum II also complete questionnaires at 6 months after the start of therapy. PROJECTED ACCRUAL: A total of 375 patients will be accrued for this study.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Sir Charles Gairdner Hospital - Perth, Perth, Western Australia, Australia
Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels, , Belgium
Cliniques Universitaires Saint-Luc, Brussels, , Belgium
Universitair Ziekenhuis Gent, Ghent, , Belgium
Virga Jesse Hospital, Hasselt, , Belgium
Cazk Groeninghe - Campus Maria's Voorzienigheid, Kortrijk, , Belgium
U.Z. Gasthuisberg, Leuven, , Belgium
Rigshospitalet, Copenhagen, , Denmark
Hopital Jean Bernard, Poitiers, , France
Universitaetsklinikum Bonn, Bonn, , Germany
Universitaets-Krankenhaus Eppendorf, Hamburg, , Germany
Spedali Civili, Brescia, , Italy
Istituto Scientifico H. San Raffaele, Milano, , Italy
Azienda Ospedaliera Maggiore Della Carita, Novara, , Italy
Universita di Palermo, Palermo, , Italy
Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino, Torino, , Italy
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, , Netherlands
Onze Lieve Vrouwe Gasthuis, Amsterdam, , Netherlands
Academisch Medisch Centrum, Amsterdam, , Netherlands
Rijnstate Hospital, Arnhem, , Netherlands
Academisch Ziekenhuis Groningen, Groningen, , Netherlands
University Medical Center Nijmegen, Nijmegen, , Netherlands
University Medical Center Rotterdam at Erasmus Medical Center, Rotterdam, , Netherlands
Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, , Netherlands
St. Elisabeth Ziekenhuis, Tilburg, , Netherlands
Norwegian Radium Hospital, Oslo, , Norway
Inselspital, Bern, Bucarest, , Romania
Institute of Oncology - Bucarest, Bucarest, , Romania
Marmara University Hospital, Istanbul, , Turkey
Dokuz Eylul University School of Medicine, Izmir, , Turkey
Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom
Velindre Cancer Center at Velinde Hospital, Cardiff, Wales, United Kingdom
University of Wales College of Medicine, Cardiff, Wales, United Kingdom
Contact Details
Name: Neil K. Aaronson, PhD
Affiliation: The Netherlands Cancer Institute
Role: STUDY_CHAIR
Name: George Van Andel, MD
Affiliation: Onze Lieve Vrouwe Gasthuis
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
